Business Development Director
Nicholas has over 18 years of experience in business development and has led Business Development groups at, and been on the Executive Teams of, Antisoma, Clavis Pharma and Redx Pharma. Over this time Nicholas has led or been instrumental in a range of global deals (including in-and out-licensing, divestments, spin-outs, royalty buy-out and M&A) with Big Pharma and biotechs; the out-licensing and divestment deals generated over US$240m. He started his career in clinical development, mainly in oncology, with Ciba-Geigy, Eisai and Cephalon. Nicholas has a degree in Biology and post-graduate diplomas from the College of Law, London. Nicholas joined OxSonics as Business Development Director in February 2019.